VPBT Holdings — ProFund VP Biotechnology
All 148 reported holdings of ProFund VP Biotechnology (VPBT) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Agpxx | 2.39% | $998.60K |
| Apellis Pharmaceuticals Inc | 1.79% | $746.15K |
| Alkermes PLC | 1.41% | $590.23K |
| Madrigal Pharmaceuticals Inc | 1.35% | $562.21K |
| TG Therapeutics Inc | 1.32% | $548.99K |
| Insmed Inc | 1.30% | $543.70K |
| Scholar Rock Holding Corp. | 1.26% | $527.73K |
| Apogee Therapeutics Inc. | 1.25% | $522.44K |
| Protagonist Therapeutics Inc | 1.21% | $506.45K |
| Summit Therapeutics Inc. | 1.21% | $504.81K |
| United Therapeutics Corporation | 1.21% | $504.63K |
| Praxis Precision Medicines Inc | 1.21% | $502.94K |
| Arrowhead Pharmaceuticals Inc | 1.20% | $500.22K |
| Cogent Biosciences Inc. | 1.18% | $494.52K |
| Bridgebio Pharma Inc | 1.16% | $482.17K |
| PTC Therapeutics, Inc. | 1.15% | $480.93K |
| Cytokinetics Inc | 1.15% | $480.15K |
| Alnylam Pharmaceuticals Inc. | 1.15% | $478.77K |
| Exelixis, Inc. | 1.14% | $476.21K |
| Nuvalent Inc | 1.14% | $474.65K |
| Kymera Therapeutics Inc | 1.13% | $473.59K |
| CG Oncology Inc. | 1.13% | $472.81K |
| Natera Inc. | 1.13% | $471.58K |
| Neurocrine Biosciences Inc | 1.13% | $471.37K |
| Twist Bioscience Corporation | 1.13% | $470.07K |
| Krystal Biotech Inc | 1.13% | $469.63K |
| Vaxcyte Inc | 1.12% | $468.19K |
| Mirum Pharmaceuticals Inc. | 1.12% | $466.70K |
| Amicus Therapeutics Inc. | 1.12% | $466.45K |
| Travere Therapeutics Inc | 1.12% | $465.44K |
| Ionis Pharmaceuticals, Inc. | 1.12% | $465.41K |
| Arcellx Inc | 1.11% | $465.37K |
| Regeneron Pharmaceuticals, Inc. | 1.11% | $462.04K |
| Incyte Corporation. | 1.10% | $460.91K |
| Celcuity Inc. | 1.09% | $457.02K |
| Revolution Medicines Inc | 1.08% | $452.60K |
| Halozyme Therapeutics Inc | 1.08% | $450.66K |
| Rhythm Pharmaceuticals Inc | 1.07% | $447.81K |
| Biogen Inc | 1.07% | $446.23K |
| Arcutis Biotherapeutics Inc. | 1.06% | $443.14K |
| AbbVie Inc. | 1.06% | $442.81K |
| Gilead Sciences Inc. | 1.06% | $442.50K |
| CRISPR Therapeutics AG | 1.06% | $441.64K |
| Biomarin Pharmaceutical Inc. | 1.04% | $434.13K |
| Roivant Sciences Ltd | 1.04% | $434.09K |
| Amgen Inc. | 1.03% | $431.72K |
| ImmunityBio Inc | 1.03% | $429.91K |
| Beam Therapeutics Inc. | 1.01% | $423.55K |
| Viking Therapeutics Inc. | 1.01% | $421.82K |
| Vera Therapeutics Inc. | 1.01% | $420.85K |
| Moderna Inc | 1.01% | $420.73K |
| Vertex Pharmaceuticals Incorporated | 1.01% | $420.19K |
| Erasca Inc | 1.00% | $418.96K |
| Acadia Pharmaceuticals Inc | 1.00% | $415.62K |
| Sarepta Therapeutics Inc | 0.87% | $363.85K |
| Agios Pharmaceuticals Inc | 0.86% | $357.21K |
| Ultragenyx Pharmaceuticals Inc | 0.85% | $356.17K |
| Disc Medicine Inc | 0.85% | $353.97K |
| Immunome Inc | 0.84% | $351.12K |
| Immunovant Inc | 0.84% | $348.75K |
| BioCryst Pharmaceuticals Inc. | 0.83% | $346.59K |
| Veracyte Inc | 0.83% | $344.97K |
| Dyne Therapeutics Inc. | 0.82% | $340.92K |
| Catalyst Pharmaceuticals Inc. | 0.74% | $307.22K |
| Syndax Pharmaceuticals Inc. | 0.72% | $299.43K |
| Denali Therapeutics Inc | 0.71% | $297.33K |
| IDEAYA Biosciences Inc. | 0.71% | $296.85K |
| Spyre Therapeutics Inc | 0.71% | $295.07K |
| GRAIL Inc | 0.71% | $294.37K |
| Viridian Therapeutics Inc | 0.68% | $285.40K |
| Recursion Pharmaceuticals Inc | 0.67% | $280.98K |
| Kodiak Sciences Inc | 0.67% | $280.11K |
| Soleno Therapeutics Inc | 0.66% | $273.97K |
| Dianthus Therapeutics Inc | 0.65% | $269.30K |
| Intellia Therapeutics Inc | 0.63% | $263.18K |
| Mineralys Therapeutics Inc. | 0.63% | $262.69K |
| Arcus Biosciences Inc. | 0.61% | $255.57K |
| Ardelyx Inc | 0.60% | $251.07K |
| Adma Biologics Inc | 0.58% | $242.32K |
| Nurix Therapeutics Inc. | 0.57% | $238.17K |
| Tango Therapeutics Inc. | 0.54% | $225.66K |
| Celldex Therapeutics Inc. | 0.51% | $212.05K |
| Novavax Inc | 0.50% | $207.81K |
| Oruka Therapeutics Inc | 0.49% | $204.10K |
| Olema Pharmaceuticals Inc. | 0.48% | $201.52K |
| Stoke Therapeutics Inc | 0.48% | $200.44K |
| Vericel Corporation | 0.47% | $196.37K |
| Capricor Therapeutics Inc | 0.47% | $194.80K |
| Palvella Therapeutics Inc. | 0.45% | $186.85K |
| Biohaven Ltd | 0.43% | $177.84K |
| Monte Rosa Therapeutics Inc | 0.42% | $176.87K |
| Corvus Pharmaceuticals Inc | 0.41% | $169.31K |
| Iovance Biotherapeutics Inc | 0.37% | $156.19K |
| AnaptysBio Inc. | 0.37% | $155.29K |
| Relay Therapeutics Inc | 0.37% | $154.02K |
| Uniqure N.V. | 0.36% | $151.70K |
| ORIC Pharmaceuticals Inc. | 0.36% | $150.37K |
| Mannkind Corporation | 0.35% | $146.42K |
| Caredx Inc | 0.34% | $140.46K |
| Taysha Gene Therapies Inc. | 0.33% | $137.77K |
| Tyra Biosciences Inc | 0.33% | $137.19K |
| Geron Corp. | 0.32% | $135.30K |
| Day One Biopharmaceuticals Inc. | 0.31% | $130.46K |
| Precigen Inc | 0.30% | $126.96K |
| VIR Biotechnology Inc | 0.30% | $123.77K |
| KalVista Pharmaceuticals Inc. | 0.28% | $118.53K |
| Cytomx Therapeutics Inc | 0.28% | $115.84K |
| Annexon Inc | 0.28% | $115.73K |
| Kura Oncology Inc. | 0.27% | $112.09K |
| Inhibrx Biosciences Inc. | 0.26% | $108.91K |
| Sellas Life Sciences Group Inc | 0.26% | $108.43K |
| Janux Therapeutics Inc | 0.26% | $108.18K |
| Compass Therapeutics Inc | 0.26% | $106.48K |
| Savara Inc | 0.25% | $106.03K |
| Rigel Pharmaceuticals Inc. | 0.25% | $104.70K |
| Sana Biotechnology Inc | 0.25% | $104.65K |
| Cullinan Therapeutics Inc | 0.24% | $101.47K |
| ARS Pharmaceuticals Inc | 0.23% | $97.07K |
| Zenas BioPharma Inc. | 0.23% | $96.77K |
| Xencor Inc | 0.22% | $93.67K |
| Replimune Group Inc | 0.22% | $93.15K |
| Vor Biopharma Inc. | 0.22% | $92.61K |
| Sionna Therapeutics Inc. | 0.22% | $91.20K |
| ArriVent BioPharma Inc. | 0.21% | $88.31K |
| Ironwood Pharmaceuticals, Inc. | 0.19% | $78.14K |
| Bicara Therapeutics Inc. | 0.19% | $77.69K |
| Prime Medicine Inc | 0.18% | $77.10K |
| Absci Corp. | 0.18% | $74.29K |
| Altimmune Inc. | 0.18% | $73.21K |
| Emergent Biosolutions Inc | 0.17% | $72.67K |
| Allogene Therapeutics Inc | 0.17% | $70.80K |
| Hyperliquid Strategies Inc. | 0.17% | $69.46K |
| 4D Molecular Therapeutics Inc | 0.16% | $68.31K |
| Vanda Pharmace Inc | 0.16% | $65.55K |
| Regenxbio Inc. | 0.15% | $63.62K |
| Lexeo Therapeutics Inc | 0.14% | $59.52K |
| Verastem Inc | 0.14% | $59.43K |
| Arbutus Biopharma Corp. | 0.14% | $56.82K |
| Myriad Genetics Inc. | 0.13% | $54.11K |
| Prothena Corporation PLC | 0.13% | $53.21K |
| Ocugen Inc. | 0.13% | $52.62K |
| Rocket Pharmaceuticals Inc | 0.12% | $51.95K |
| MiMedx Group Inc. | 0.12% | $50.19K |
| Akebia Therapeutics Inc. | 0.11% | $46.73K |
| Anavex Life Sciences Corp. | 0.11% | $45.35K |
| Invivyd Inc | 0.10% | $40.92K |
| Perspective Therapeutics Inc | 0.10% | $39.77K |
| Damora Therapeutics Inc. | 0.03% | $13.52K |
VPBT overview: performance, fees, allocation and SEC filings